Researcher in lab

Find clinical trials

Our clinical trial portfolio is one of the largest in the country. We have more than 600 clinical trials open across 30 clinical units.

Find Melbourne Sexual Health Centre research studies and clinical trials
Clear filter
604 clinical trials found
Clinical trials

SuperQoL

Assessing the impact of an intensive dietitian-led telehealth intervention focusing on nutritional adequacy and symptom control, on quality of life in patients with pancreatic cancer: a randomised control trial. (ACTRN12624000084583)

Currently recruiting

SURFACE ONCOLOGY

A Randomized Phase 2 Trial of Atezolizumab and Bevacizumab in Combination With SRF388 or Placebo in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma (NCT05359861)

Currently recruiting

SWIFT

Symptom monitoring WIth Feedback Trial (SWIFT) (ACTRN12620001061921)

Coming soon

SYNCOPE-STOPPER

The Syncope-Stopper study: comparison of upfront pacing with standard care for high-risk patients with unexplained syncope. (ACTRN12622001553763)

Currently recruiting

TAIHO 10058060

A Phase 1 study of TAS-116 (pimitespib) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (NCT05245968)

Currently recruiting

TAK-079-3002

A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Safety of Mezagitamab Subcutaneous Injection in Participants with Chronic Primary Immune Thrombocytopenia (NCT06722235)

Currently recruiting

TAK-279-PsO-3003

A Phase 3, Multicenter, Open-Label Study to Evaluate the Long-term Safety, Tolerability, and Efficacy of TAK-279 in Subjects with Moderate-to-Severe Plaque Psoriasis (NCT06550076)

Currently recruiting

Takeda Tak-279-3001

A Phase 3, Randomized, Multicenter, Double-Blind, Placebo- and Active Comparator-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Subjects With Moderate-to-Severe Plaque Psoriasis (NCT06088043)

No longer recruiting

TAKEDA-DS-DB

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Young Adult Subjects With Dravet Syndrome (DS) (NCT04940624)

Currently recruiting

TAKEDA-LGS-DB

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Study to Evaluate the Efficacy, Safety, and Tolerability of Soticlestat as Adjunctive Therapy in Pediatric and Adult Subjects With Lennox-Gastaut Syndrome (LGS) (NCT04938427)

Currently recruiting

TAKEDA-OLE

A Phase 3, Prospective, Open-Label, Multisite, Extension of Phase 3 Studies To Assess the Long-Term Safety and Tolerability of Soticlestat as Adjunctive Therapy in Subjects With Dravet Syndrome or Lennox-Gastaut Syndrome (NCT05163314)

Currently recruiting

Target-Tau

CN008-0003: A Phase 2, Randomized, Double-blind, Placebo-controlled, Multicenter Study Assessing the Efficacy, Safety and Tolerability of an Anti-MTBR Tau Monoclonal Antibody, in Participants with Early Alzheimer's Disease (NCT06268886)

Currently recruiting

Tas-120-205

Phase 2 Study of Futibatinib 20 mg and 16 mg in Patients with Advanced Cholangiocarcinoma with FGFR2 Fusions or Rearrangements (NCT05727176)

Currently recruiting

TAURUS.2

A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis (ACTRN12622000064707)

Recently completed/closed

TEBE-AM

Phase 2/3 Randomized Study of Tebentafusp as Monotherapy and in Combination with Pembrolizumab Versus Investigator’s Choice in HLA-A*02:01-positive Participants with Previously Treated Advanced Melanoma (TEBE-AM) (NCT05549297)

Currently recruiting

TELO-SCOPE

The TELO-SCOPE Study: Attenuating Telomere Attrition with Danazol. Is there Scope to Dramatically Improve Health Outcomes for Adults and Children with Pulmonary Fibrosis? (NCT04638517)

Currently recruiting

TETON-2

A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (TETON-2) (NCT05255991)

Currently recruiting

The AIM Study

Determine whether analgesia for patients undergoing minimally invasive major abdominal surgery using Intrathecal Morphine with local anaesthetic affects quality of recovery. The AIM Study (ACTRN12623001347651)

Coming soon

The Alison Project

The Alison Project: A randomised double-blind placebo controlled investigation of adjunctive memantine in the treatment of symptoms of complex trauma disorder (also known as borderline personality disorder) (NCT02097706)

Currently recruiting

The SMART-AF study

The SMART-AF study (ACTRN12625000481471)

Currently recruiting
26 27 28 29 30